This article discusses the origin and consolidation of the Chinese Communist Party (CCP) reserve cadre system and considers its impact on the resilience and perpetuation of the Party's authoritarian regime. Reserve cadres are essentially the Party's “disciples”; through careful selection and training, the CCP is able to build a legion of youthful political elites with exceptional administrative ability and correct political thinking. Upon assumption of Party and government posts, these reserve cadres are able to reinforce the Party's autonomy and resist outside pressures to democratize, thereby manifesting the very nature of a resilient authoritarian regime.
The PLA has been a key player in Chinese elite politics since 1949. However, a series of developments over the last four years has prompted China watchers to re-evaluate Party–military relations. This paper argues that CCP–PLA relations in the Xi Jinping era are characterized by the centralization of power in a single civilian individual. This centralization is reflected by events such as a new emphasis on the CMC chairman responsibility system, the establishment of new coordination bodies under the top leader, radical reforms to the military command structure, the promotion of Xi's public image as the top leader, and large-scale personnel reshuffes during which Xi's trustees have gradually come to occupy key military posts while his rivals have been removed. For Xi, these measures are an antidote to the principal–agent problem in CCP–PLA relations caused by both information asymmetry and the discrepant interests of civilian leaders and the top brass of the PLA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.